Biomarin Pharmaceutical Inc (BMRN)

Current ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Total current assets	US$ in thousands	3,232,430	3,056,590	3,259,630	2,985,010	2,956,090	2,955,310	2,950,120	2,842,100	2,751,460	2,682,700	2,517,600	2,394,020	2,274,380	2,311,570	2,357,840	2,288,770	2,342,220	2,738,980	2,647,570	2,116,250
Total current liabilities	US$ in thousands	606,988	715,658	1,067,340	1,087,900	1,177,020	1,163,220	597,231	598,231	588,884	521,020	464,727	490,418	546,497	514,898	443,344	430,035	492,548	854,693	813,302	820,470
Current ratio		5.33	4.27	3.05	2.74	2.51	2.54	4.94	4.75	4.67	5.15	5.42	4.88	4.16	4.49	5.32	5.32	4.76	3.20	3.26	2.58

December 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $3,232,430K ÷ $606,988K
= 5.33

The current ratio of Biomarin Pharmaceutical Inc has exhibited fluctuations over the quarters. It increased steadily from March 31, 2020, where it stood at 2.58, to reach its peak at 5.42 on June 30, 2022. Since then, there has been a slight decline in the ratio, but it remains relatively high, indicating a strong ability to cover short-term obligations with current assets. However, there was a notable decrease in the ratio to 2.51 as of December 31, 2023, and it further dropped to 2.51 on March 31, 2024.

Overall, Biomarin's current ratio has shown a generally favorable trend, reflecting the company's ability to meet its short-term obligations comfortably. It is important for stakeholders to monitor future changes in the ratio to ensure the company maintains a healthy liquidity position.